Literature DB >> 33409749

Quantitative evaluation of retinal and choroidal changes in Fabry disease using optical coherence tomography angiography.

Zhongjing Lin1, Xiaoxia Pan2, Ke Mao1, Qin Jiao3, Yanwei Chen4, Yisheng Zhong5, Yu Cheng6.   

Abstract

To examine the retinal and choroidal changes in patients with Fabry disease (FD) using optical coherence tomography angiography (OCTA). FD patients and age- and sex-matched healthy subjects were enrolled. A detailed ophthalmological examination was performed for all participants. The retinal thickness, ganglion cell layer with inner plexiform layer (GCIPL) thickness, choroidal thickness (CT), vessel length density (VLD), vessel perfusion density (VPD), and foveal avascular zone (FAZ) were analyzed in a detailed way with OCTA. Moreover, all FD patients underwent several laboratory tests to evaluate systemic conditions. A total of 54 subjects comprising 26 FD patients and 28 normal controls were enrolled. The retinal thickness, GCIPL thickness, and FAZ area showed no significant differences between the two groups (all P > 0.05). Only the superior CT in FD patients was significantly thinner than that in the normal subjects (P = 0.040). The macular VLD and VPD in the FD group were significantly reduced compared with the healthy controls (P = 0.026, P = 0.008). The macular VLD in FD patients had no significant correlations with different laboratory results (all P > 0.05), while the macular VPD were negatively correlated with creatinine (r = - 0.432, P = 0.028) and cystatin C (r = - 0.422, P = 0.032). FD patients may have retinal vascular dropout and choroidal vascular alterations. Analysis of vessel density using OCTA might be useful in the clinical assessment in FD patients.
© 2021. The Author(s), under exclusive licence to Springer-Verlag London Ltd. part of Springer Nature.

Entities:  

Keywords:  Choroidal thickness; Fabry disease; Optical coherence tomography angiography; Vessel density

Mesh:

Year:  2021        PMID: 33409749     DOI: 10.1007/s10103-020-03242-5

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  26 in total

1.  Retinal and choroidal vascular changes in heterozygous Fabry disease.

Authors:  M A Dantas; R A Fonseca; T Kaga; L A Yannuzzi; R F Spaide
Journal:  Retina       Date:  2001       Impact factor: 4.256

2.  Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.

Authors:  Andrea Sodi; Alexander S Ioannidis; Atul Mehta; Clare Davey; Michael Beck; Suzanne Pitz
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

Review 3.  Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder.

Authors:  Nasi Samiy
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

4.  Sequential bilateral central retinal artery occlusions in a female carrier of Fabry disease.

Authors:  Kelly T Mitchell; Jay C Bradley; Laura S Gilmore; Gary E Meyerrose
Journal:  Clin Exp Ophthalmol       Date:  2009-09       Impact factor: 4.207

Review 5.  Fabry disease.

Authors:  Toshinori Yuasa; Toshihiro Takenaka; Koji Higuchi; Nami Uchiyama; Yoshihisa Horizoe; Hideto Cyaen; Naoko Mizukami; Kunitsugu Takasaki; Akira Kisanuki; Masaaki Miyata; Mitsuru Ohishi
Journal:  J Echocardiogr       Date:  2017-07-03

6.  Cilioretinal artery occlusion and anterior ischemic optic neuropathy as the initial presentation in a child female carrier of Fabry disease.

Authors:  M Giray Ersoz; Gamze Ture
Journal:  Int Ophthalmol       Date:  2017-03-09       Impact factor: 2.031

7.  Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement.

Authors:  Hans C Fledelius; Lisbeth Sandfeld; Åse Krogh Rasmussen; Christoffer V Madsen; Ulla Feldt-Rasmussen
Journal:  Acta Ophthalmol       Date:  2014-12-09       Impact factor: 3.761

Review 8.  Anderson-Fabry disease: a multiorgan disease.

Authors:  Antonino Tuttolomondo; Rosaria Pecoraro; Irene Simonetta; Salvatore Miceli; Antonio Pinto; Giuseppe Licata
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  Fabry disease: a review of ophthalmic and systemic manifestations.

Authors:  Melanie D Sivley
Journal:  Optom Vis Sci       Date:  2013-02       Impact factor: 1.973

10.  Fabry disease: a survey of visual and ocular symptoms.

Authors:  Pinakin Gunvant Davey
Journal:  Clin Ophthalmol       Date:  2014-08-19
View more
  1 in total

1.  Retinal biomarkers of Cerebral Small Vessel Disease: A systematic review.

Authors:  Elena Biffi; Zachary Turple; Jessica Chung; Alessandro Biffi
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.